Advanced Antimicrobial Stewardship Curriculum (Global)

 

The IDSA Advanced Antimicrobial Stewardship (AS) curriculum provides you with the knowledge and skills to become a leader in antimicrobial stewardship and is intended for those who are considering or actively pursuing a career in antimicrobial stewardship. It builds upon the IDSA CORE AS Curriculum, which provides fellows with a broad foundation in antimicrobial stewardship. 

As with the CORE curriculum, the Advanced curriculum is designed for use at your home institution and builds on local AS resources. The content is organized into 5 main sections and includes eLearning modules, workbooks, and application activities. 

Target Audience

Fellows/Trainees interested in leading an Antimicrobial Stewardship Program.

Learning Objectives

Upon completion of this section, you will be able to:

  • Develop a comprehensive antimicrobial stewardship program by defining overall goals, optimizing team structure, and carrying out regulatory and reporting aspects of stewardship
  • Analyze local microbiology and antimicrobial data and use it to identify and implement impactful antimicrobial stewardship initiatives
  • Apply behavioral psychology principles and leverage business principles to increase resources for antimicrobial stewardship and influence culture change by creating effective programmatic antimicrobial stewardship communication approaches
  • Evaluate and plan the most effective diagnostic and antibiotic stewardship interventions for unique populations and settings (specifically the emergency department, immunocompromised populations, long-term care facilities, and outpatient sites)
  • Identify resources for professional development in antimicrobial stewardship to be able to begin a career in antimicrobial stewardship
  • Develop a plan to expand the reach of a stewardship program into the outpatient setting and  effectively collaborate with OPAT programs to optimize stewardship efforts
Course summary
Course opens: 
07/01/2023
Course expires: 
07/15/2025

Advanced AS Curriculum Workgroup COI Summary Reviewed April 2017 by Rachel Simmons, MD No conflicts found.

All relevant financial relationships have been mitigated.

NameIndividual's role in activityName of commercial interestNature of Relationship
Advani, SonaliWorkgroup MemberNone 
Armstrong, WendyWorkgroup MemberNone 
Barsoumian, AliceWorkgroup MemberNone 
Beeler, ColeWorkgroup MemberNone 
Bennani, KenzaStaffNone 
Blair, BarbraWorkgroup MemberNone 
Brennan - Krohn, TheaWorkgroup MemberNone 
Bryson - Cahn, ChloeWorkgroup MemberNone 
Cherabuddi, KartikWorkgroup MemberNone 
Fong, GaryWorkgroup MemberCritical Innovations, LLCAdvisory/Consultant Role
Gaston, DavidWorkgroup MemberNone 
Hamilton, KeithWorkgroup MemberNone 
Holubar, MarisaWorkgroup MemberNone 
Huang, MishaWorkgroup MemberNone 
Ince, DilekWorkgroup MemberGilead Science’s Clinical Studies for remdesivir Principal Investigator
  Accelerate DiagnosticsResearch Grants/Contracts
  LeidosResearch Grants/Contracts
Justo, Julie AnnWorkgroup MemberbioMerieuxOther remuneration - Speaker's Bureau
  MerckAdvisory/Consultant Role
  VaxartStocks/Bonds
Kang, AmyWorkgroup MemberNone 
Larnard, JeffWorkgroup MemberNone 
Lee, MatthewWorkgroup MemberNone 
Logan, AshleighStaffNone 
Luther, VeraWorkgroup MemberNone 
MacDougal, ConanWorkgroup MemberNone 
Melia, MichaelWorkgroup MemberMerckOrganizational Benefit
  AllerganOrganizational Benefit
  Pfizer; MelintaOrganizational Benefit
Miller, MattWorkgroup MemberAbbvieHonoraria
  La JollaHonoraria
  MerckResearch Grant/Contract
Moenster, RyanWorkgroup MemberShionogiAdvisory/Consultant Role, Honoraria
  Abbvie/AllerganAdvisory/Consultant Role, Honoraria
  Melinta TherapeuticsAdvisory/Consultant Role, Honoraria
  MerckAdvisory/Consultant Role, Honoraria
Nori, PriyaWorkgroup MemberMerckCo-infections in COVID-19 patients
Paras, MollyWorkgroup MemberNone 
Patel, PayalWorkgroup MemberNone 
Rodvold, KeithWorkgroup MemberBLC USA LPAdvisory/Consultant Role, Honoraria
  VenatoRxAdvisory/Consultant Role, Honoraria
  Medicine Company/Qpex BiopharmaAdvisory/Consultant Role, Honoraria
  Vemco Med Ed. (Merck CME/CPE programs)Advisory/Consultant Role, Honoraria
  DebipharmAdvisory/Consultant Role, Honoraria
  ShionogiAdvisory/Consultant Role, Honoraria
   Unrestricted education grant for CME/CPE Program
  Utility TherapeuticsAdvisory/Consultant Role, Honoraria
  JanssenData Safety Monitoring Board (DSMB)
  Clinartis LLC (projects associated with Spero Therapeutics and Sinovent)Advisory/Consultant Role, Honoraria
  USCAST : US Ctte on Antimicrobial Susceptibility TestingVoting Committee Member
Schooneveld, TrevorWorkgroup MemberRebiotix, MerkResearch Grant
  Thermo - FischerSpeaking
Schwartz, BrianWorkgroup MemberNone 
Spicer, JenniferWorkgroup MemberNone 
Stack, ConorWorkgroup MemberNone 
Stead, WendyWorkgroup MemberNone 
Stohs, EricaWorkgroup MemberReviral LtdResearch Grant
Wiley, ZanthiaWorkgroup MemberNone 
Willis, ZacharyWorkgroup MemberNone 
Shnekendorf, RachelStaffNone 

Vaezi, Liza

Workgroup MemberNone 
Rachel SimmonsReviewerNone 

 

This version of the curriculum is not accredited for CME or MOC.
 
Status
Price
Title
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
Please login or register to take this course.

 

 

Required Hardware/software

PCs Running Window

  • Windows 10  
  • Microsoft Edge
  • Firefox
  • Google Chrome

Apple Computers Running OSX

  • Safari
  • Firefox
  • Google Chrome